Lonza appoints Pierre-Alain Ruffieux as new Chief Executive Officer June 5, 2020 BASEL, SWITZERLAND: The Board of Lonza announced today that Pierre-Alain Ruffieux has been appointed Chief Executive Officer effective 1 November 2020. Prior to that…
Glycotest receives $3mn second tranche of $10mn Series A financing November 21, 2019 NEW YORK: Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis, has received the second…